Michael G. Grey, Director at Mirum Pharmaceuticals, Inc. (MIRM), sold 14,608 shares at $28.00 ($409K) on 2023-05-03, disclosed to the SEC on 2023-05-04.
Scheduled sale ($409k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2025-11-25 | $3.5M | — | Filing → |
| MIRM | SELL | 2023-09-14 | $467K | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |